MedPath

Evaluation of Nail Fold Microcirculation in CKD

Phase 4
Conditions
Chronic Renal Disease
Interventions
Registration Number
NCT03682952
Lead Sponsor
The Affiliated Hospital of Xuzhou Medical University
Brief Summary

To evaluation of nailfold microcirculation in patients with chronic renal failure and its intervention therapy

Detailed Description

The aim of this study is to study the changes of Nailfold Microcirculation in patients with chronic renal failure, to clarify the correlation between the changes of Nailfold Microcirculation and renal function, and to explore whether nailfold microcirculation can be used as an indicator of renal microcirculation in patients with chronic renal failure, and to provide a noninvasive method for the clinical evaluation of renal microcirculation in patients with chronic renal failure.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • CKD patients
  • Without dialysis
  • Blood pressure ≤ 140/90mmHg
Exclusion Criteria
  • Polycystic kidney
  • Endocrine system disease
  • Cardio-cerebrovascular disease
  • Rheumatic immune disease
  • Peripheral vascular disease
  • Hematological diseases
  • Respiratory disease
  • Infection

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimental groupAlprostadil InjectionAlprostadil and Beraprost sodium tablets are used to improve the microcirculation of CKD patients.
Experimental groupBeraprost sodium tabletsAlprostadil and Beraprost sodium tablets are used to improve the microcirculation of CKD patients.
Primary Outcome Measures
NameTimeMethod
Nailfold microcirculation morphological integralUp to three and a half months

Nail fold capillary microscopy examination

Nailfold microcirculation blood flow integralUp to three and a half months

Nail fold capillary microscopy examination

Nail fold microcirculation perivascular loop integralUp to three and a half months

Nail fold capillary microscopy examination

Secondary Outcome Measures
NameTimeMethod
The content of blood urea nitrogenUp to three and a half months

Intravenous blood sampling,uronoscopy

The content of blood cystatin CUp to three and a half months

Intravenous blood sampling

eGFRUp to three and a half months

Intravenous blood sampling

The content of blood serum creatinineUp to three and a half months

Intravenous blood sampling

The content of blood albuminUp to three and a half months

Intravenous blood sampling

The quantification of urinary proteinUp to three and a half months

Uronoscopy

The content of hemoglobinUp to three and a half months

Intravenous blood sampling

Trial Locations

Locations (1)

The Affiliated Hospital of Xuzhou Medical University

🇨🇳

Xuzhou, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath